EMLA Patch empl 2 pce

7680529800119 CH-52980 N01BB20 01.02.2.

Reimbursement limitations:

EMLA

Pour des enfants jusqu'à 16 ans et des patients dialysés.

EMLA Patch empl 2 pce
EMLA Patch empl 2 pce
EMLA Patch empl 2 pce
1 / 3
google

Details

Product number
5298001
CPT
-
Packaging group
2
Unit
Pflaster
Composition
Tela cum emulsione 1g/9.6 cm², lidocainum 25 mg, prilocainum 25 mg, excipiens ad emulsionem pro 1 g.

Articles (1)

Emla Patch, Pflaster
Pflaster
2
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/09/2025
Patient information leaflet
Français
15/09/2025
Patient information leaflet
Italien
15/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
19.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 13.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2005

Authorization holder

Aspen Pharma Schweiz GmbH

6340 Baar

Authorization information

Swissmedic authorization number
52980
Drug name
Emla Patch, wirkstoffhaltiges Pflaster
Galenic form
WIRSP
ATC Code
N01BB20
Authorization status
Z
Dispensation category
B
First authorization
14/11/1995
Authorization expiration date
31/12/9999
IT number
01.02.2.
Domain
Human medicine
Field of application
Anästhesie der Haut

Packaging details

Description (FR)
EMLA Patch empl 2 pce
Description (DE)
EMLA Patch Pfl 2 Stk
Market launch
14/11/1995
Narcotic (BTM)
No

Available generics

Other packaging sizes

EMLA Patch empl 20 pce
20 PFLA
View